Research programme: chronic kidney disease vaccine - AFFiRiSAlternative Names: CKD vaccine - AFFiRiS
Latest Information Update: 20 Jun 2014
At a glance
- Originator AFFiRiS
- Class Peptide vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Renal failure
Most Recent Events
- 20 Jun 2014 Preclinical trials in Renal failure (Chronic kidney disease) in Austria (Parenteral)